Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Harvard Business School
Boehringer Ingelheim
McKesson
AstraZeneca

Last Updated: October 6, 2022

Details for New Drug Application (NDA): 018890


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


NDA 018890 describes METRONIDAZOLE IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare Corp, Gland Pharma Ltd, Hospira, Inforlife, and Rising, and is included in five NDAs. It is available from eight suppliers. Additional details are available on the METRONIDAZOLE IN PLASTIC CONTAINER profile page.

The generic ingredient in METRONIDAZOLE IN PLASTIC CONTAINER is metronidazole. There are eighteen drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
Summary for 018890
Tradename:METRONIDAZOLE IN PLASTIC CONTAINER
Applicant:Hospira
Ingredient:metronidazole
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 018890
Medical Subject Heading (MeSH) Categories for 018890
Suppliers and Packaging for NDA: 018890
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METRONIDAZOLE IN PLASTIC CONTAINER metronidazole INJECTABLE;INJECTION 018890 NDA Henry Schein, Inc. 0404-9911 0404-9911-00 1 BAG in 1 BAG (0404-9911-00) > 100 mL in 1 BAG
METRONIDAZOLE IN PLASTIC CONTAINER metronidazole INJECTABLE;INJECTION 018890 NDA Hospira, Inc. 0409-7811 0409-7811-24 24 POUCH in 1 CASE (0409-7811-24) > 1 BAG in 1 POUCH > 100 mL in 1 BAG (0409-7811-31)

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength500MG/100ML
Approval Date:Nov 18, 1983TE:APRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Harvard Business School
McKesson
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.